Differences in genetic variation in antigen-processing machinery components and association with cervical carcinoma risk in two Indonesian populations

Immunogenetics

Volumn 67, Issue 5-6, 2015, Pages 267-275

  Mehta, Akash M ^a,b   Spaans, Vivian M ^b   Mahendra, Nyoman Bayu ^c   Osse, Elisabeth M ^b   Vet, Jessica N I ^b   Purwoto, Gatot ^d   Surya, I G D ^e   Cornian, Santoso ^d   Peters, Alexander A ^b   Fleuren, Gert J ^b   Jordanova, Ekaterina S ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Department of Gynecology and Obstetrics   (Indonesia)

^d UNIVERSITY OF INDONESIA   (Indonesia)

^e UDAYANA UNIVERSITY   (Indonesia)

Author keywords

Antigen processing machinery; Cervical carcinoma; Genetic variation; Haplotype interaction; Human papilloma virus; Indonesia; Single nucleotide polymorphisms

Indexed keywords

ALLELE; ANTIGEN PRESENTATION; CARCINOMA; FEMALE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HAPLOTYPE; HUMAN; IMMUNOLOGY; INDONESIA; PATHOLOGY; POPULATION GENETICS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR;

ALLELES; ANTIGEN PRESENTATION; CARCINOMA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, POPULATION; HAPLOTYPES; HUMANS; INDONESIA; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84939976181     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-015-0834-5     Document Type: Article

References (29)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265
2. Becker T, Knapp M (2004) A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 75:561–570
3. Becker T, Cichon S, Jonson E, Knapp M (2005a) Multiple testing in the context of haplotype analysis revisited: application to case-control data. Ann Hum Genet 69:747–756
4. Becker T, Schumacher J, Cichon S, Baur MP, Knapp M (2005b) Haplotype interaction analysis of unlinked regions. Genet Epidemiol 29:313–322
5. Cao B, Tian X, Li Y, Jiang P, Ning T, Xing H, Zhao Y, Zhang C, Shi X, Chen D, Shen Y, Ke Y (2005) LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis 26:1280–1284
6. Chang CC, Ferrone S (2007) Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother 56:227–236
7. Chow RA, Caeiro JL, Chen SJ, Garcia-Bertrand RL, Herrera RJ (2005) Genetic characterization of four Austronesian-speaking populations. J Hum Genet 50:550–559
8. Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, Campoli M, Ferrone S (2005) Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res 11:8304–8311
9. Falk K, Rotzschke O (2002) The final cut: how ERAP1 trims MHC ligands to size. Nat Immunol 3:1121–1122
10. Hammer GE, Gonzalez F, Champsaur M, Cado D, Shastri N (2006) The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 7:103–112
11. Hanley JA (2001) A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 55:508–514
12. Heemels MT, Ploegh H (1995) Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 64:463–491
13. Hennig G, Gehrmann M, Stropp U, Brauch H, Fritz P, Eichelbaum M, Schwab M, Schroth W (2010) Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression. Clin Chem 56:1845–1853
14. Kaufman J (2013) Antigen processing and presentation: evolution from a bird's eye view. Mol Immunol 55:159–161
15. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal 14:143–149
16. Mehta AM, Jordanova ES, van Wezel T, Uh HW, Corver WE, Kwappenberg KM, Verduijn W, Kenter GG, van der Burg SH, Fleuren GJ (2007) Genetic variation of antigen processing machinery components and association with cervical carcinoma. Genes Chromosom Cancer 46:577–586
17. Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ (2008) Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 57:197–206
18. Mehta AM, Jordanova ES, Corver WE, van Wezel T, Uh HW, Kenter GG, Fleuren GJ (2009) Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma. Genes Chromosom Cancer 48:410–418
19. Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B (2005) Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Clin Cancer Res 11:2552–2560
20. Miettinen OS (1974) Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 99:325–332
21. Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, Tsujimoto M, Goldberg AL (2002) An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3:1169–1176
22. Sasieni PD (1997) From genotypes to genes: doubling the sample size. Biometrics 53:1253–1261
23. Saveanu L, Carroll O, Lindo V, Del Val M, Lopez D, Lepelletier Y, Greer F, Schomburg L, Fruci D, Niedermann G, van Endert PM (2005) Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 6:689–697
24. Seliger B, Ritz U, Ferrone S (2006) Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer 118:129–138
25. Shepard EM, Chow RA, Suafo'a E, Addison D, Perez-Miranda AM, Garcia-Bertrand RL, Herrera RJ (2005) Autosomal STR variation in five Austronesian populations. Hum Biol 77:825–851
26. Vet JN, de Boer MA, van den Akker BE, Siregar B, Lisnawati, Budiningsih S, Tyasmorowati D, Moestikaningsih, Cornain S, Peters AA, Fleuren GJ (2008) Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer 99:214–218
27. Yan J, Parekh VV, Mendez-Fernandez Y, Olivares-Villagomez D, Dragovic S, Hill T, Roopenian DC, Joyce S, Van Kaer L (2006) In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 203:647–659
28. York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, Rock KL (2002) The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3:1177–1184
29. York IA, Brehm MA, Zendzian S, Towne CF, Rock KL (2006) Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci USA 103:9202–9207